Hims & Hers Health (NYSE:HIMS) versus SBC Medical Group (NASDAQ:SBC) Critical Survey

Hims & Hers Health (NYSE:HIMS) and SBC Medical Group (NASDAQ:SBC) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, dividends and risk.

Volatility and Risk

Hims & Hers Health has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, SBC Medical Group has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500.

Profitability

This table compares Hims & Hers Health and SBC Medical Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	8.19%	10.97%	8.29%
SBC Medical Group	N/A	-11.59%	-7.05%

Earnings & Valuation

This table compares Hims & Hers Health and SBC Medical Group”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$872.00 million	7.74	-$23.55 million	$0.44	70.20
SBC Medical Group	N/A	N/A	$340,000.00	N/A	N/A

SBC Medical Group has lower revenue, but higher earnings than Hims & Hers Health.

Insider & Institutional Ownership

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are owned by institutional investors. 17.7% of Hims & Hers Health shares are owned by insiders. Comparatively, 63.9% of SBC Medical Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings for Hims & Hers Health and SBC Medical Group, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2	7	8	0	2.35
SBC Medical Group	0	0	0	0	0.00

Hims & Hers Health currently has a consensus target price of $25.13, indicating a potential downside of 18.63%. Given Hims & Hers Health’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Hims & Hers Health is more favorable than SBC Medical Group.

Summary

Hims & Hers Health beats SBC Medical Group on 9 of the 11 factors compared between the two stocks.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.